UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes

NCT06751199 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: human umbilical cord mesenchymal stem cells
DRUG: allogeneic islet

Sponsor

Shanghai Changzheng Hospital